Hung David 4
4 · NovoCure Ltd · Filed Jun 3, 2026
Research Summary
AI-generated summary of this filing
NovoCure (NVCR) Director David Hung Sells 2,945 Shares
What Happened David Hung, a director of NovoCure Ltd (NVCR), disposed of 2,945 shares on 2026-06-02 in an open-market sale. The weighted-average sale price was $15.77, for total proceeds of approximately $46,445. This was a sale (not a purchase) and was executed to satisfy tax withholding obligations related to vested restricted stock units — a non-discretionary, issuer-mandated "sell-to-cover" action.
Key Details
- Transaction date: 2026-06-02 (reported on Form 4 filed 2026-06-03) — filing appears timely.
- Shares sold: 2,945; weighted-average price: $15.77; total proceeds ≈ $46,445.
- Price range: executed in multiple trades between $15.65 and $15.88 (weighted avg reported).
- Reason/footnote: Sale mandated to cover tax withholding on RSU vesting (sell-to-cover), not a discretionary trade by the reporting person.
- Shares owned after transaction: not specified in the provided data.
Context Sell-to-cover transactions are common when restricted stock units vest and do not necessarily signal an insider view on the company's prospects. This Form 4 reports a routine tax-withholding sale rather than a voluntary investment decision.
Insider Transaction Report
- Sale
Ordinary Shares
[F1][F2]2026-06-02$15.77/sh−2,945$46,445→ 20,465 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]This transaction was executed in multiple trades at prices ranging from $15.65 USD to $15.88 USD; the price reported above reflects the weighted average sale price.